Key result
Coronary artery surgery improved survival compared to medical treatment over 5.5 years in subgroups including patients with two- or three-vessel disease and ejection fraction ≥30%.
Authors
Loading...
Supports CABG over medical therapy for survival in two- or three-vessel disease with LVEF ≥30%; confirms RCT benefit at 5.5 years.
Cohort
DeRouen et al. (1981) conducted a cohort in coronary artery disease. coronary artery surgery vs. medical treatment was evaluated on survival. Coronary artery surgery improved survival compared to medical treatment over 5.5 years in subgroups including patients with two- or three-vessel disease and ejection fraction ≥30%.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: